Blau Farmacêutica Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	43.2	33.32	31.5	14.11	51.86	70.2
Short-Term Investments	-	459.56	375.82	629.53	870.96	144.15
Cash & Short-Term Investments	310.78	492.87	407.31	643.65	922.82	214.35
Cash Growth	-28.05%	21.00%	-36.72%	-30.25%	330.52%	34.76%
Accounts Receivable	521.76	476.75	453.56	420.61	331.79	247.55
Other Receivables	100.78	100.34	64.35	44.58	13.66	9.22
Receivables	622.54	577.09	517.91	465.19	345.45	256.78
Inventory	710.4	606.19	628.65	569.02	416.85	327.49
Other Current Assets	325.44	-	-	-	11.35	1.88
Total Current Assets	1,969	1,676	1,554	1,678	1,696	800.5
Property, Plant & Equipment	937.88	829.04	738.71	542.48	371.58	244.05
Long-Term Investments	-	265.16	265.19	-	0.04	0.03
Goodwill	151.66	151.66	151.66	143.24	143.24	144.64
Other Intangible Assets	62.51	53.81	24.83	16.57	5.75	3.48
Long-Term Deferred Tax Assets	78.25	84.52	81.53	-	-	15.87
Long-Term Deferred Charges	377.28	282.28	177.58	74.25	49.82	21.64
Other Long-Term Assets	44.32	69.12	60.17	44.65	61.14	42.43
Total Assets	3,621	3,412	3,054	2,499	2,328	1,273
Accounts Payable	268.5	286	179.92	163.64	116.43	133
Accrued Expenses	98.81	90.21	55.62	56.78	55.2	42.16
Short-Term Debt	51.95	1.87	2.3	-	41.73	15.81
Current Portion of Long-Term Debt	172.32	65.1	67.92	79.87	49.82	47.01
Current Portion of Leases	6.65	6.39	4.8	3.67	2.11	1.44
Current Income Taxes Payable	32.93	8.92	-	19.44	19.99	36.23
Other Current Liabilities	48.44	79.46	25.38	47.71	57.72	88.19
Total Current Liabilities	679.59	537.94	335.93	371.11	343.01	363.83
Long-Term Debt	283.33	450	500	200	272.5	626.33
Long-Term Leases	30.92	35.59	33.52	28.17	8.35	0.38
Long-Term Deferred Tax Liabilities	215.45	170.2	125.64	35.02	18.25	-
Other Long-Term Liabilities	76.99	67.33	63.2	46.81	51.05	60.74
Total Liabilities	1,286	1,261	1,058	681.11	693.16	1,051
Common Stock	1,317	1,317	1,317	1,317	1,317	100.64
Retained Earnings	1,096	899.32	744.37	562.8	325.13	84.64
Treasury Stock	-42.89	-42.89	-42.89	-39.9	-	-
Comprehensive Income & Other	-19.58	-9.05	-16.62	-17.36	-5.45	36.07
Total Common Equity	2,350	2,164	2,001	1,822	1,636	221.34
Minority Interest	-15.38	-13.33	-6.22	-4.22	-1.4	-
Shareholders' Equity	2,335	2,151	1,995	1,818	1,635	221.34
Total Liabilities & Equity	3,621	3,412	3,054	2,499	2,328	1,273
Total Debt	545.17	558.95	608.54	311.71	374.52	690.96
Net Cash (Debt)	-234.39	-66.08	-201.22	331.93	548.3	-476.61
Net Cash Growth	-	-	-	-39.46%	-	-
Net Cash Per Share	-1.01	-0.29	-0.87	1.44	2.35	-2.33
Filing Date Shares Outstanding	230.98	230.98	230.98	231.18	233.21	192.4
Total Common Shares Outstanding	230.98	230.98	230.98	231.18	233.21	192.4
Working Capital	1,290	1,138	1,218	1,307	1,353	436.67
Book Value Per Share	10.17	9.37	8.66	7.88	7.02	1.15
Tangible Book Value	2,136	1,959	1,825	1,662	1,487	73.22
Tangible Book Value Per Share	9.25	8.48	7.90	7.19	6.38	0.38
Machinery	426.27	338.57	302.14	170.92	135.22	121.52
Construction In Progress	297.86	296.26	257.03	210.19	194.06	84.28

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.